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ABSTRACT
Previous studies have identified UGCAUG as an
intron splicing enhancer that is frequently located
adjacent to tissue-specific alternative exons in the
human genome. Here, we show that UGCAUG is
phylogenetically and spatially conserved in introns
that flank brain-enriched alternative exons from fish
to man. Analysis of sequence from the mouse, rat,
dog, chicken and pufferfish genomes revealed a
strongly statistically significant association of
UGCAUGwiththeproximalintronregiondownstream
of brain-enriched alternative exons. The number,
position and sequence context of intronic UGCAUG
elements were highly conserved among mammals
and in chicken, but more divergent in fish. Control
datasets, including constitutive exons and non-
tissue-specific alternative exons, exhibited a much
lower incidence of closely linked UGCAUG elements.
We propose that the high sequence specificity of the
UGCAUG element, and its unique association with
tissue-specific alternative exons, mark it as a critical
component of splicing switch mechanism(s)
designed to activate a limited repertoire of splicing
events in cell type-specific patterns. We further
speculate that highly conserved UGCAUG-binding
protein(s) related to the recently described Fox-1
splicing factor play a critical role in mediating this
specificity.
INTRODUCTION
Alternative pre-mRNA splicing is a prominent feature of
human gene expression, and is often credited with allowing
a relatively small number of genes to encode an extremely
complex proteome. Particularly intriguing and physiologically
relevant is the subset of alternative exons that exhibit
developmental- or differentiation-speciﬁc expression,
i.e. exons whose splicing is switched on and off in a highly
regulated manner. Such alternative splicing switches probably
play a major role in deﬁning the specialized properties of
differentiated mammalian cells by facilitating expression of
cell type-speciﬁc subsets of the total proteome. Understanding
the mechanisms by which splicing switches are regulated is
thus critical to a better appreciation of specialization in
metazoan organisms.
The molecular switch that mediates inclusion or exclusion
of an alternative exon is generally thought to be regulated by
the antagonistic activities of splicing factor proteins that
interact at positive-acting enhancer elements versus those
binding at negative-acting silencer elements in the RNA
(1–3). Signiﬁcant progress in identifying cis-regulatory
elements in the exons has been made by large-scale screening
of RNA sequences to identify those that bind to known spli-
cing factors and/or exhibit functional enhancer or silencer
activity (4–11). Increasingly, computational approaches are
also contributing to the identiﬁcation of candidate splicing
regulatory elements. Large-scale sequence comparisons
have identiﬁed several classes of exon splicing enhancers
(ESEs) and intron splicing enhancers (ISEs) based on their
over-representation in or near exons with weak splice sites
(12,13). Computational analysis of sequence motifs important
for constitutive splicing hasalsobeen reported (14).Finally, as
more examples of tissue-speciﬁc exons are annotated, another
promising strategy for identiﬁcation of regulatory elements
involves computational analysis of specialized datasets of
exons exhibiting shared expression patterns (15). Importantly,
development of algorithms that predict splicing enhancer
elements are improving our ability to recognize new classes
of splicing defects that underlie many human diseases (16,17).
Critical splicing regulatory motifs are often located in the
introns, and it is interesting to note that such elements play a
prominent role in a number of regulated alternative splicing
events (2,18–23). Recently, (U)GCAUG elements have been
characterized experimentally as intronic splicing regulatory
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sequences for novel splicing factors of the Fox-1 family of
RNA binding proteins (26). Computational analysis showed
further that the UGCAUG hexamer is dramatically over-
represented in the proximal downstream intron sequences
of many brain-speciﬁc exons (15). Together these ﬁndings
suggested the intriguing hypothesis that Fox proteins may
play a critical role in mediating developmental and
differentiation-speciﬁc splicing switches.
Here, we show that (U)GCAUG association with regulated
exons has been highly evolutionarily conserved in the
downstream proximal introns near tissue-speciﬁc exons of
vertebrates from ﬁsh to humans. In many cases, number,
position and sequence context of (U)GCAUG elements has
been strongly conserved, supporting the hypothesis that this
element is a critical component of the splicing switch
mechanism that mediates tissue-speciﬁc splicing events.
MATERIALS AND METHODS
Collection of tissue-specific alternative exon and
control exon datasets
‘Tissue-speciﬁc alternative exon’ datasets were related to the
human brain-enriched exons studies earlier (15), modiﬁed so
astoremoveverysmall(<12nt)andverylargeexons(>500nt),
and to add a few newly recognized brain-enriched exons.
These new genes include exons in EPB41L3 (28),
EPB41L1 (28), ANK1 (29), BAIAP (30), DCAMKL1 (31),
DNM3, EWSR (32), MYH10 (33) and PTBP2 (34) genes.
For phylogenetic analysis, the orthologous exons were
identiﬁed in the mouse, rat, dog, chicken and pufferﬁsh
genomes using VISTA alignment tools supplemented,
where necessary, by manual analysis. Automatic alignment
was successful at ﬁnding most of the longer alternative
exons directly. However, some of the shorter exons lacked
sufﬁcient homology to be easily detected at the nucleotide
level. In these cases, the ﬂanking constitutive exons were
identiﬁed, and a conceptual translation of the intervening
sequence was successful in identifying the alternative exon.
‘Tissue non-speciﬁc alternative exons’ were derived from
theEuropeanBioinformaticsInstitutedatabaseofhumanalter-
native exons (http://www.ebi.ac.uk/asd/altextron/index.html),
using the so-called cryptic exon database. The ﬁrst 100 exons
in this dataset were extracted and ﬂanking intron sequences
retrieved for computational analysis.
‘Control exon databases’ were generated from randomly
selected chromosomal regions by extraction from RefSeq
annotation databases to get exon coordinates. Control groups
for the mammalian and chicken genomes contained at least
several hundred exons. Due to the absence of a VISTA align-
ment for the dog genome, we utilized the human control data-
set for comparative purposes. For Fugu, constitutive exons
were extracted from the remainder of the genes in which
the brain-enriched exons reside. These control datasets
presumably represent predominantly constitutively spliced
exons and were used as a reference against which to estimate
the statistical signiﬁcance ofsequences over-represented inthe
alternative exon datasets.
The brain-enriched datasets and the control datasets are
available at http://gsd.lbl.gov/splicing/.
Computational analysis
Candidate regulatory elements were predicted computation-
ally by identifying oligonucleotide sequences (or words) that
were over-or under-represented ineach tissue-speciﬁc dataset,
relative to the control datasets. The frequencies of each word
were calculated at any selected range, relative to the exon
boundaries, using the algorithm described previously (15).
For each word, a contrast score was calculated as the differ-
ence in frequency in the tissue-speciﬁc dataset versus the
control dataset. The statistical signiﬁcance of contrast scores
was estimated using resampling statistics as described (15)
with the following modiﬁcation. In this paper, the probability
refers to the chance that any hexamer might exhibit a given
contrast score in a randomly selected subset of the control
sample (equal in size to the brain sample).
RT–PCR analysis
Tissue-speciﬁc splicing patterns of selected transcripts were
characterized using RT–PCR techniques to amplify speciﬁed
RNAregionsfromseveraldifferentmousetissuesources.RNA
was prepared using RNeasy columns according to the manu-
facturer’s instructions (Qiagen, Valencia, CA). One micro-
gram of total RNA was transcribed into cDNA using
random hexamer primers in a total volume of 10 ml. Then,
2 ml cDNA was ampliﬁed using the following primers:
ACVR2, forward, 50-CACCGAAGCCACCCTATTACAAC-30;
reverse, 50-CCCCTTGCTTTCACTTCTAACAGC-30; EPB41L1s,
forward, 50-TGCCTCAGTCAGTGAGAATCACG-30;
reverse, 50-GGTGCTTCAACAAGACATCCTCTG-30;
EPB41l1b, forward, 50-GCATCAATGAACTCAAGAGGA-
CCC-30; reverse, 50-TTCTTCCTGATTGCCAGACTGC-30;
EPB41L3s, forward, 50-AAGACAGAAGGAAGAAGGCT-
GAGG-30; reverse, 50-TCCCACTCGTTTGTTAAGGCAG-30;
EPB41L3b, forward, 50-CCAAGTGTGACTGAGAAAACA-
CAGG-30; reverse, 50-CATGCCTCTCCTCTACCAGTATCG-30;
NF1, forward, 50-GACTGTCTTGTCTCTTGCTTTCGG-30;
reverse, 50-CACAGCCTTGCACTGCTTTATG -30; MYH10,
50-GTCATTCAGTACCTTGCCCACG-30; reverse, 50-CGC-
ATTTCCAAAGGATTCCAG-30; SCN8a, forward, 50-TAT-
GCGGACAAGGTCTTCACCTAC-30; reverse, 50-ATCGG-
ATCTCTGTGTTGTTGCC-30; PTBP2, forward, 50-AGG-
AGACATCCCTACTAGCTGTTCC-30; reverse, 50-CATCA-
GCCATCTGTATCAGAGCAC-30. Thirty-ﬁve cycles of
ampliﬁcation were performed under the following conditions:
denaturation for 30 s at 94 C; annealing for 30 s at 55 C;
extension for 60 s at 72 C. DNA fragments were analyzed
by 5% polyacrylamide gel electrophoresis. The identity of
PCR products was conﬁrmed by DNA sequence analysis.
RESULTS
Identification of orthologous tissue-specific exons in
several species
A group of 27 tissue-speciﬁc, alternatively spliced, cassette
exons with predominant expression inthe brain was assembled
for this study. Table 1 shows the RefSeq names of the human
genes in which these exons reside, as well as the size in nuc-
leotidesandthe hg16/NCBIbuild34coordinates foreach exon
in the human genome. As described in Methods and also as
shown in Table 1, the orthologs for most of these exons were
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mouse, rat, dog and chicken (indicated by ‘+’). In addition,
the pufferﬁsh orthologs of 11 of these exons were also
identiﬁed. The DNA sequences for each alternative exon
were retrieved, along with 1 kb of upstream and downstream
intron, to create ﬁve new tissue-speciﬁc datasets for the three
mammalian species (mouse, rat, dog), one avian species
(chicken) and one piscine species (pufferﬁsh). These
sequences, together with large datasets of control exon/intron
sequences for each species, were used for computational
analysis of candidate splicing regulatory elements.
Phylogenetic conservation of intronic UGCAUG sites
In the original dataset of brain-speciﬁc exons in the human
genome, UGCAUG sites were preferentially localized to the
proximal downstream intron (15), with greatest enrichment of
sites in the ﬁrst 100 nt downstream (here deﬁned as the D100
region). We hypothesized that, if UGCAUG is an important
splicing regulatory element, it should be evolutionarily con-
served near the orthologous alternative exons in other species.
This hypothesis was tested by subjecting each of the species-
speciﬁc datasets to computational analysis with a word search
algorithm. Oligonucleotide frequencies were counted and con-
trast scores computed to quantitate the over-representation of
candidate regulatory elements in the tissue-speciﬁc exon data-
sets relative to the control datasets of non-tissue-speciﬁc exons
(see Methods). A high contrast score therefore suggests that a
sequence may be important for regulated alternative splicing
but not for constitutive splicing.
Table 2 lists the top ten over-expressed hexamers in each
species-speciﬁc database,rankedinorderbycontrastscore,for
the proximal intron region 0–400 nt downstream of the exons
(the D400 region). Similar to our earlier study, UGCAUG was
themostover-representedhexamerinthehumandatasetwitha
contrast score of 2.29. This was by far the highest contrast
score for any unique hexamer in the D400 region, and it was
the only statistically signiﬁcant score (P < 0.05), using a con-
servative measure of the probability that any hexamer would
be over-represented to this extent in a dataset of this size.
Remarkably, UGCAUG was the most over-represented
hexamer observed in the D400 region for all ﬁve additional
species including mouse, rat, dog, chicken and even pufferﬁsh.
In all cases, the contrast scores were statistically signiﬁcant
(P < 0.05) and far higher for UGCAUG than for any other
hexamer. Moreover, in all of these datasets UGCAUG was
either ﬁrst or second in absolute abundance among all 4096
hexamers within the D400 region (Table 2).
Because the binding speciﬁcity of the zebraﬁsh Fox-1
splicing factor was recently reported as the pentamer
GCAUG (35), we examined the proportion of total
GCAUG motifs in the D400 region that occur in the context
of the UGCAUG hexamer. Notably, for all six species the
great majority (65–93%) of all GCAUG motifs in the D400
regiondoresideinaUGCAUGhexamer(Table3A).AGCAUG
consistently ranked second, with 7–20% of the total, while
CGCAUG and GGCAUG represented a small minority of
cases. Only the UGCAUG hexamer possessed a statistically
signiﬁcant contrast score. This result suggests, at least in the
datasets examined here, that UGCAUG plays a functionally
dominant role in splicing regulation, and that GCAUG or the
related hexamers may be involved in regulating a smaller
subset of alternative splicing events. It remains to be determ-
inedastowhetherthesameFox-1splicingfactoroperatesatall
of these sites via tolerance of sequence variation at position 1,
Table 1. Brain-enriched alternatively spliced exons examined in this study
Gene name Exon size (nt) Human coordinates, July 03 Mouse Rat Dog Chicken Fugu
1 ACVR2 24 chr2:148879875–148879898(+) ++ + + +
2 ANK1 24 chr8:41575288–41575311( ) ++ + +
3 ATP2B4 178 chr1:200879784–200879961(+) ++ + +
4 BAIAP 84 chr3:65330156–65330239( ) ++ + +
5 BIN1 93 chr2:127919008–127919100( ) ++ +
6 CACNCB1 63 chr9:136130205–136130267(+) ++ + + +
7 CLTB 54 chr5:175804403–175804456( ) ++ + + +
8 DCAMKL1 74 chr13:34160349–34160422( ) ++ + + +
9 DLG1 36 chr3:198121894–198121929( ) ++ + +
10 DNM3 30 chr1:169302212–169302241(+) ++ + +
11 EPB41L1 36 chr20:35498680–35498715(+) ++ + +
12 EPB41L1 411 chr20:35512839–35513249(+) ++ + +
13 EPB41L3 36 chr18:5397700–5397735( ) ++ + +
14 EPB41L3 123 chr18:5388021–5388143( ) ++ + +
15 EWSR 18 chr22:27994808–27994835(+) ++ + +
16 FHL1 200 chrX:133997009–133997208(+) ++ +
17 GABRG2 24 chr5:161558631–161560654(+) ++ + +
18 GRIN1 63 chr9:135399897–135399959(+) ++ + + +
19 KSR 42 chr17:26073950–26073991(+) ++ + + +
20 MAG 45 chr19:40495024–40495068(+) ++
21 MYH10 30 chr17:8680527–8680556( ) ++ + + +
22 MYH10 63 chr17:8634507–8634569( ) ++ + + +
23 NF1 30 chr17:29675683–29675712(+) ++ +
24 PTPB2 34 chr1:96743776–96743809(+) ++ + + +
25 PTPRF 27 chr1:43480037–43482062(+) ++ + + +
26 SCN8a 123 chr12:50460700–50460822(+) ++ + + +
27 SRC 18 chr20:36700292–36700309(+) ++ + + +
(+) and ( ) indicate the direction of transcription for the selected genes.
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region D400
Sequence Brain
frequency
·10
 3 (rank)
Control
frequency
·10
 3 (rank)
Contrast
score
P-value
Human
UGCAUG 2.53 (1) 0.25 (1310) 2.29 0.031*
UUUUAA 1.72 (2) 0.28 (1103) 1.44 0.240
UUUGUU 1.72 (2) 0.39 (718) 1.33 0.301
UUGUUU 1.63 (5) 0.36 (822) 1.28 0.343
UGUUUU 1.72 (2) 0.45 (555) 1.27 0.347
UGCUUU 1.63 (5) 0.37 (759) 1.26 0.357
UUUUAU 1.45 (7) 0.21 (1563) 1.24 0.375
UCAUUU 1.36 (9) 0.22 (1459) 1.14 0.494
UUUAUU 1.36 (9) 0.24 (1384) 1.12 0.506
GCAUGC 1.27 (11) 0.20 (1597) 1.07 0.580
Mouse
UGCAUG 2.36 (1) 0.54 (283) 1.81 0.030*
CUGCAU 1.45 (5) 0.38 (836) 1.07 0.391
UUUCUG 1.72 (2) 0.66 (124) 1.07 0.396
AUUUUA 1.36 (7) 0.41 (706) 0.95 0.575
UUUAAA 1.27 (9) 0.42 (627) 0.85 0.803
CAUUUG 1.09 (20) 0.28 (1512) 0.81 0.867
UGAUUU 1.09 (20) 0.35 (1016) 0.74 0.964
ACCAGG 1.18 (13) 0.44 (561) 0.74 0.969
UGCUUU 1.18 (13) 0.45 (528) 0.73 0.974
UUUUAA 1.18 (13) 0.45 (482) 0.71 0.983
Rat
UGCAUG 3.03 (1) 0.46 (374) 2.56 0.028*
CUGCAU 2.05 (2) 0.30 (1283) 1.75 0.119
UGCUUC 1.46 (4) 0.43 (468) 1.03 0.543
UGUCUG 1.66 (3) 0.67 (53) 0.99 0.594
GCAUGC 1.17 (15) 0.29 (1453) 0.89 0.780
GCAUGU 1.17 (15) 0.36 (791) 0.81 0.908
UCGCUG 0.88 (54) 0.08 (3151) 0.79 0.927
CCCUCU 1.37 (6) 0.58 (112) 0.78 0.941
CCCACC 1.27 (9) 0.50 (264) 0.76 0.958
CUGAUU 1.07 (25) 0.31 (1192) 0.76 0.962
Dog
UGCAUG 2.73 (1) 0.25 (1310) 2.49 0.024*
UGUUUU 1.76 (2) 0.45 (555) 1.31 0.360
UUUGUU 1.66 (3) 0.39 (718) 1.27 0.391
UUUUUG 1.66 (3) 0.44 (588) 1.22 0.447
UGCUUU 1.56 (5) 0.37 (759) 1.19 0.488
AUUUUU 1.56 (5) 0.40 (685) 1.16 0.521
UCCUUU 1.46 (8) 0.32 (935) 1.14 0.552
UUUAUU 1.37 (9) 0.24 (1384) 1.13 0.565
UUUGCU 1.37 (9) 0.30 (1041) 1.07 0.654
CUGCAU 1.37 (9) 0.30 (1023) 1.06 0.663
Chicken
UGCAUG 2.12 (2) 0.50 (340) 1.62 0.017*
UGUUUU 2.22 (1) 1.02 (4) 1.19 0.199
GUUUUU 1.69 (4) 0.71 (52) 0.98 0.553
UUUGUU 1.80 (3) 0.91 (13) 0.89 0.778
UUUUUU 1.69 (4) 0.84 (19) 0.85 0.859
CAUGCU 1.27 (14) 0.44 (515) 0.83 0.906
AUGCAU 1.16 (19) 0.36 (890) 0.80 0.941
CUUUUU 1.48 (8) 0.69 (62) 0.79 0.951
UAUAUA 0.95 (53) 0.19 (2299) 0.77 0.977
UGGUUC 0.95 (53) 0.21 (2089) 0.74 0.987
Fugu
UGCAUG 3.00 (1) 0.61 (227) 2.39 0.010*
UUAAAU 1.62 (6) 0.22 (1635) 1.39 0.789
CCAUUU 1.62 (6) 0.28 (1290) 1.34 0.807
UUUUUC 2.08 (2) 0.77 (76) 1.30 0.884
GGAUGG 1.38 (16) 0.11 (2562) 1.27 0.893
AAAUGG 1.38 (16) 0.11 (2562) 1.27 0.893
UGUGUG 1.85 (4) 0.61 (227) 1.24 0.956
UUGCAU 1.62 (6) 0.39 (757) 1.23 0.956
AUAAUC 1.38 (16) 0.17 (2041) 1.22 0.956
CUUUUU 1.85 (4) 0.66 (163) 1.18 0.964
*Indicates results that are statistically significant (P-value < 0.05).
Table 3. Nucleotide preferences flanking GCAUG and UGCAUG
Human Mouse Rat Dog Chicken Fugu
(A) Abundance of hexamers containing GCAUG in the D400 region
UGCAUG 28
(65%)
28
(74%)
31
(79%)
26
(74%)
20
(67%)
13
(93%)
AGCAUG 8
(19%)
5
(13%)
5
(13%)
5
(14%)
6
(20%)
1
(7%)
CGCAUG 4 2 2 3 2 0
GGCAUG 3 3 1 1 2 0
(B) Abundance of heptamers containing UGCAUG in the D400 region
UUGCAUG 9 8 6 6 7 6
CUGCAUG 11 11 13 11 6 2
AUGCAUG 5 6 8 4 5 3
GUGCAUG 3 4 4 5 2 2
UGCAUGU7 1 0 8 7 5 5
UGCAUGC 769 6 4 1
UGCAUGA 778 8 6 2
UGCAUGG 766 5 5 5
Underlined residues indicate nucleotides flanking the core GCAUG or
UGCAUG motif.
or whether distinct Fox-1 related splicing factor(s) bind to
hexamers that vary at position 1.
Finally, we asked whether there is any extended sequence
preference for UGCAUG hexamers in these brain-enriched
datasets. Heptamer sequences containing UGCAUG were
therefore analyzed to test for nucleotide preferences ﬂanking
the core hexamer. As shown in Table 3B, there is a moderate
preference (61–71%) for a pyrimidine nucleotide preceding
UGCAUG in all six species (P-values: 0.0178 for human,
0.068 for mouse, 0.140 for rat, 0.131 for chicken, 0.0843
for dog and 0.290 for Fugu). Analysis of larger datasets
may be necessary to provide a better test of signiﬁcance.
No marked preference for any particular nucleotide immedi-
ately following the UGCAUG motif was observed. Together
these results suggest that the hexamer UGCAUG is the
functional motif shared among many brain-enriched exons.
UGCAUG is a marker of tissue-specific
alternative exons
Although this study focused on a group of brain-enriched
exons, (U)GCAUG has also been reported as an enhancer
of alternative exons with different tissue-speciﬁc regulation
(24,25,27). We therefore proposed that UGCAUG is a marker
speciﬁcally of regulated alternative splicing, but not a general
markerforallalternativeexons.Asatestofthishypothesis,we
examined the association of UGCAUG with a larger dataset of
non-tissue-speciﬁc alternative exons. For this purpose, we
used a group of 100 alternative exons compiled in the
European Bioinformatics Institute database (see Methods).
When the word counting algorithm was applied to this dataset,
the results revealed both similarities and marked differences
compared with the brain-enriched datasets (Table 4). Notably,
the top ten contrast scores of the non-tissue-speciﬁc dataset
were all very U-rich and G-deﬁcient, similar to what was
observed in the brain-enriched datasets. However, the non-
tissue-speciﬁc group differed from the regulated group in
one critical respect: there was no signiﬁcant over-
representation of the UGCAUG hexamer in proximal intron
sequences of the unregulated group. Among all possible
hexamers, UGCAUG ranked as the most over-represented
sequence in the D400 region of the human brain-enriched
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the non-tissue-speciﬁc dataset of human alternative exons.
This marked difference persisted when the analysis was
expanded to include the entire 1 kb ﬂanking intron sequences:
almost 90% (24/27) of the human brain-enriched exons
possessed UGCAUG within 1 kb upstream or downstream,
whereas only 48% (47/99) of the non-tissue-speciﬁc exons
did so. The latter frequency is not signiﬁcantly different
from random chance.
Distribution of UGCAUG motifs relative to
the regulated exons
Our data demonstrates that UGCAUG is frequently localized
to the D400 region; however, previous studies have shown that
UGCAUG motifs can function at a distance of at least 1 kb
from the regulated exon (26). To examine the spatial distri-
bution of UGCAUG motifs in the introns ﬂanking brain-
enriched exons, we repeated oligonucleotide counts at
100 nt intervals upstream and downstream of the regulated
exons. This analysis demonstrated that the highest frequency
of UGCAUG occurred within the D400 region for all six
species-speciﬁc datasets (Figure 1). A more modest frequency
of UGCAUG elements, but still elevated in comparison to the
very low incidence of UGCAUG hexamers ﬂanking non-
tissue-speciﬁc alternative exons (Figure 1, bottom panel),
was observed further downstream and in the upstream intron
region.
Additional insight into the distribution of conserved
UGCAUG hexamers was provided by phylogenetic analysis
of individual orthologous exons in the brain-enriched datasets.
Figure 2 shows the conserved UGCAUG elements that map
near individual tissue-speciﬁc exons in the brain datasets.
Conserved elements were deﬁned as hexamers that exhibited
a similarpositionandsequencecontextintwoormorespecies;
sporadic elements that occurred in only one species, which
were included in the spatial distributions shown in Figure 1,
were eliminated from this revised map. Many of these phylo-
genetically conserved elements were located within 10–400 nt
of downstream intron sequence (shaded region); fully 70%
(19/27) of these exons possessed at least one conserved
UGCAUG in the D400 region. However, several highly
conserved UGCAUG elements were located in more distal
intronic regions, both upstream and downstream of the regu-
lated exons. In total, about 90% of the alternative exons in
the mammalian datasets possessed at least one conserved
UGCAUG hexamer within 1 kb. About half of these are spa-
tially conserved in the chicken genome, suggesting that these
candidate splicing regulatory elements have been phylo-
genetically conserved from avians to mammals. However,
although UGCAUG elements were strongly associated with
tissue-speciﬁc exons in the pufferﬁsh genome, their spatial
conservation is much reduced.
Conservation of UGCAUG sequence context
We next asked whether spatially conserved UGCAUG
elements occur within the context of a larger phylogenetically
conserved sequence that might include other important
regulatory motifs. For this purpose, we considered separately
elements that were very close to the exon, i.e. within 100 nt
versus those that mapped >250 nt downstream. The most
proximal elements within 100 nt indeed exhibit high conser-
vation of ﬂanking sequence, including the splice site
sequences (results not shown), as expected for the proximal
intron sequence of orthologous alternative exons (36). Inter-
estingly, distal UGCAUG elements also occur in a highly
conserved local sequence context. Figure 3 presents a multiple
sequence alignment for six such elements that map 250–600 nt
downstream of the regulated exon. Although distal intron
sequences are not usually conserved (36), here we observed
highconservationofprimarynucleotidesequence atleast15nt
on either side of the core UGCAUG motif. Conservation occ-
urred primarily among orthologous members of each dataset,
but no obvious sequence similarities were detected between
different exons within a dataset. This pattern of phylogenetic
conservation suggests that the functional intronic enhancer is
somewhat larger than UGCAUG alone. Future studies with
larger datasets will be essential to identify additional con-
served elements, potentially exhibiting more sequence degen-
eracy, that are associated with the unique UGCAUG motif.
We considered the possibility that sequence conservation
among intronic enhancers could be due to a shared origin of
these elements, e.g. by Alu exonization (37). However, the
brain-enriched exons in this study occur in non-primate mam-
mals, birds, and even ﬁsh, indicating that they pre-date the
evolution of Alu elements. In addition, direct sequence
analysis revealed no evidence for homology of the brain-
enriched exons and their putative intronic enhancers to Alu
elements or to other common repeat elements in the human
genome (data not shown).
Deficiency of G-triplets in the proximal downstream
intron of brain-enriched datasets
It was also of interest to examine the distribution of G triplets,
which have been reported to be over-represented in proximal
downstream introns (14,38) and to enhance exon inclusion
(39–41). Our earlier study reported that, in marked contrast
to the over-representation of UGCAUG elements near brain-
enriched exons in the human genome, the downstream intron
sequence was substantially deﬁcient in G triplets (15). To
explore whether deﬁciency of G triplets adjacent to brain-
enriched alternative exons is an evolutionarily conserved
feature, we asked which trinucleotides were most under-
represented (i.e. exhibited the highest negative contrastscores)
in each of the species-speciﬁc datasets. Notably, GGG was the
only trinucleotide to exhibit a top-ranking negative contrast
Table 4. Most over-represented hexamers in the non-tissue-specific dataset,
D400 region
Sequence Frequency in
data set ·10
 3
Frequency in
control ·10
 3
Contrast
Human
AUUUUU 1.60 0.40 1.20
UAUUUU 1.37 0.32 1.05
UUAUUU 1.19 0.26 0.93
UUUUUA 1.22 0.34 0.88
UUUUUC 1.22 0.37 0.85
UUUUUU 1.45 0.60 0.85
CUUUUU 1.24 0.42 0.83
UUCUUU 1.22 0.39 0.83
UUUAUU 1.04 0.24 0.80
UCUUUU 1.09 0.34 0.76
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species (Table 5).Interestingly,although intronic GGGtriplets
occur less frequently in pufferﬁsh than in mammals (13), they
still exhibited a negative contrast score in pufferﬁsh indicating
a reduced occurrence in regions ﬂanking regulated alternative
exons. G triplets are thus consistently much more abundant in
the proximal downstream intron of constitutive exons than in
the corresponding intron region of brain-enriched exons.
Additional analyses revealed similarly that tetramer and
hexamer sequences containing G-triplets were greatly
under-represented in the brain-enriched datasets (data not
shown). Interestingly, the tissue non-speciﬁc dataset also
exhibited a signiﬁcant deﬁciency of G triplets in the D400
region (Table 5). The latter observation suggests that lack
of GGG enhancers in the downstream intron may be a general
feature of many alternatively spliced exons, which might then
Figure 1. Enrichment of candidate UGCAUG alternative splicing enhancers in the proximal downstream intron region is conserved among vertebrate species.
Histograms show the frequency of UGCAUG elements at 100 nt intervals in the introns upstream and downstream of the brain-enriched exons. Top six panels
representtheanalysisofintronsequencesforthevertebratespeciesindicatedattheleft.NotethehighestabundanceofUGCAUGelementsisconsistentlywithinthe
downstream  400 nt (D400) region. The bottom panel shows the much lower incidence of UGCAUG elements that occurs near a group of non-tissue-specific
alternative exons. Vertical axis, frequency; horizontal axis, nucleotide range relative to the alternative exon.
Nucleic Acids Research, 2005, Vol. 33, No. 2 719require an alternative intronic enhancer (such as UGCAUG)
to activate splicing in a regulated manner.
Confirmation of tissue-specific splicing in other species
Although alternatively spliced exons are not always conserved
between human and mouse (42,43), a critical assumption
underlying the analysis of our brain-enriched exon datasets
is that the patterns of regulation for tissue-speciﬁc alternative
exons are indeed phylogenetically conserved. Thus far, most
of the published experimental data to support tissue-speciﬁc
splicing of the exons in our datasets was focused only on the
human genes. As an initial test of whether tissue-speciﬁc spli-
cing patterns were conserved in other species, we examined
the expression of selected exons in several mouse tissues.
Figure 4 summarizes the results of an RT–PCR experiment
looking at eight such exons. All eight were alternatively
spliced, as indicated by the presence of products including
CACNAB1
DNM3
CLTB
PTBP2
ATP2B4
EWSR
GRIN1
SCN8A
GABRG2
NF1
MAG
SRC
DLG1
MYH10
ANK1
EPB41L1b
FHL1
ACVR2
EPB41L1a
DCAMKL1
EPB41L3
KSR
EPB41L3b
100nt
alt
exon
MYH10( )
Figure 2. Specific location of UGCAUG hexamers near individual brain-enriched exons is highly conserved evolutionarily. The figure shows all of the brain-
enriched exons for which phylogenetically conserved UGCAUG elements were identified in the flanking introns. Location of hexamers is indicated by small
rectangles or circles that are color coded to indicate species. Blue, human; yellow, mouse; green, rat; red, dog; brown, chicken; and black circle, Fugu. Regulated
brain-enriched exons are at the center; intron sequences to the left represent upstream sequences while those to the right represent downstream sequences.
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designated alternative exon. Moreover, all exhibited tissue-
speciﬁc expression with modest to substantial inclusion in
the brain RNA sample. However, whereas several were
quite brain-speciﬁc (ACVR2, EPB41L1s, EPB41L3s,
EPB41L3b), others exhibited dual speciﬁcity for brain and
skeletal muscle (NF1, MYH10), or brain and lung (SCN8a),
or they exhibited a more complex pattern (PTBP2). These
results support the idea that the ‘brain-enriched’ exons in
our databases do exhibit a phylogenetically conserved pattern
of activated splicing in the brain. However, they also reveal
unexpected complexity in splicing patterns in other tissues,
further supporting the notion that UGCAUG elements alone
are not sufﬁcient to determine precise tissue speciﬁcity.
DISCUSSION
Previous studies have shown that UGCAUG is an intronic
splicing regulatory element (18,24,25,27), that it is bound
with unusually high speciﬁcity by the novel alternative
splicing factor, Fox-1 (35), and that it is required for efﬁcient
splicing of neural-speciﬁc alternative exons (18,44). The
demonstration that UGCAUG expression is widely associated
with brain-enriched exons (15) and is evolutionarily conserved
from ﬁsh to man (this paper) further implicates the
Fox-UGCAUG system as an important regulator of tissue-
speciﬁc alternative splicing. Taken together, these biochem-
ical and computational ﬁndings suggest a model whereby Fox
protein binding to UGCAUG plays a critical role in activating
splicing switches for many alternative exons during neural
development and differentiation.
As shown in this paper, the intronic UGCAUG motif is
phylogenetically and spatially conserved near brain-
enriched exons. The majority of these brain-enriched exons
possess at least one copy of UGCAUG in the ﬂanking intron,
and the remaining few generally have closely related GCAUG
pentameric motif(s) in the proximal intron [(15); and
from results not shown]. Evolutionary conservation of intronic
DCAMKL1  Hs +603     CTATGTATTAGCTATTGCATGAATTTATTTTTC-AA
Mm +599     CTATGTACTAGCTCCTGCATGAATTTACTTTCTGAA
         Gg +616     TTTTTTTTTAAATATTGCATGAGTCT----TCTGAA
EPB41L3  Hs +285     ATTGGTATATACCAGTGCATGTCTGTGTGTG-TTGT 
(36nt)  Mm +270     ATTGGGACCCTCCAGTGCATGCCTGTGTGTGGTGGT 
Gg +254     ATTGGTATATACCAGTGCATGTGCATACATGTGTGT
Hs +343     GGGCTCGTATTGTGATGCATGAACTGTGTGCTCATC
Mm +327     GGACCTGAATTGTGATGCATGACCGCGTTACTCAGC
Gg +310     GAACCTGCACTATGATGCATGACCTGTGTATTCCCA
EWSR  Hs +311     CCCTGAAGGATAGATTGCATGATGAGATTTATTTAG
Mm +282     CCCTGAAGGCTAGATTGCATGATTAGTTTCATTTA-
Gg +302     CCCTAAAGGGTAAACAGCATGGTTAGACGTGTCCAG
Hs +350     CAGAC-TGCCA-CCCTGCATGTATCATGTT-TGTCT
Mm +322     CAGATTTGCCA-CCCTGCATGTAT-ATGTT-TGTCT
Gg +342     T-GAC-CACCATCTCTGCATGTTTCATGTGATGTCT
GRIN1  Hs +256     CTGCTCTCCGGGAAGTGCATGCGAATCTCCGAGACC
Mm +261     CTGCTCT--GGGAAGTGCATG--AATCTCCAGGTCC
GG +247     TTTCTTTTTGAGACATGCATGTGAA---CCAGTAAT
Hs +493     GGGTCCACTTCAGCTTGCATGCTCAGTGCAAA
Mm +496     CCGTCCATTTCAGCTTGCATGCTCAGAGCAAA 
Gg +520     TGATTGACTTCAGTTTGCATGCACAGTGCAAA
Figure 3. UGCAUG hexamers are often situated within larger regions of conserved intron sequence. Local alignments of nucleotide sequences flanking several
conserved UGCAUG elements are shown. Nucleotides shared among at least two species are shaded. Notably, UGCAUG hexamers are located within regions of
conservationthatmaybeseveralhundrednucleotidesdistaltotheregulatedexon.NumbersontheleftindicatethedistanceoftheUGCAUGelementfromtheexon.
Table 5. Most under-represented trinucleotides, D400 region
Human Mouse Rat Dog Chicken Pufferfish Non-tissue-specific
*GGG  2.19 AGG  1.62 AGG  0.94 GGC  1.90 *GGG  1.10 GAU  1.13 GGC  1.84
AGG  2.00 GGA  1.08 GAA  0.75 *GGG  1.76 GAG  1.09 GGA  0.93 *GGG  1.70
GGC  1.91 CAG  0.84 GGA  0.73 GCC  1.75 AGG  1.03 *GGG  0.68 GCC  1.59
GCC  1.53 *GGG  0.82 AAA  0.47 AGG  1.74 GUG  0.73 UGA  0.67 CCC  1.19
CAG  1.47 GAG  0.79 AAU  0.43 CCC  1.43 AGC  0.70 UGG  0.64 UGG  1.05
CCC  1.20 ACA  0.50 *GGG  0.43 CAG  1.32 GGC  0.65 GCA  0.62 CGG  1.01
*Indicates the position of GGG among under-represented trinucleotides in each dataset.
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biochemical studies have demonstrated that in some cases the
GCAUG pentamer is functional in splicing assays (25,35). We
propose that the presence of linked (U)GCAUG elements may
be an essential property for a specialized subset of alternative
exons whose splicing is both tissue-speciﬁcally regulated and
phylogenetically conserved. Consistent with this model, our
studies did not identify UGCAUG in association with either
constitutive exons or non-tissue-speciﬁc alternative exons. We
speculate that other experimental approaches such as
RESCUE-ISE (13) and the use of support vector machines
(45) have not yet identiﬁed UGCAUG as a candidate regulat-
ory element only because they have not been applied to the
analysis of tissue-speciﬁc alternative exons. Almost certainly,
these powerful techniques will be invaluable for future studies
of splicing regulatory elements.
Alternativeexons typicallyexhibithigherphylogenetic con-
servation of proximal intron sequences than do constitutive
exons (43). Presumably, this conservation reﬂects a functional
role in regulation of alternative splicing; our analyses begin to
reveal speciﬁc functional motifs characteristic of these con-
served introns. Besides the over-representation of UGCAUG
elements, introns ﬂanking alternative exons are modestly
deﬁcient in purines in general, and highly deﬁcient in
G-triplets in particular, compared with the introns ﬂanking
control exons. This was a robust ﬁnding in all six species-
speciﬁc brain datasets examined in the study. Since G-triplets
have been shown to enhance splicing of neighboring exons
(39–41), it is tempting to speculate that the absence of this
widely expressed class of intronic enhancers may contribute to
the default skipping phenotype of many alternative exons. The
ability to efﬁcientlyactivate splicing of these exons might then
require another class of intronic enhancer, e.g. the UGCAUG
elementoranalogous motifs,inordertoachieve tissue-speciﬁc
regulation during development and differentiation. Alternative
exons that lack both G-triplets and UGCAUG element(s)
might represent a separate class that does not exhibit tissue-
speciﬁc switching.
We propose that the functional importance of the UGCAUG
motif is to serve as a critical cis-acting component of alter-
native splicing switches that trigger many developmental-
and differentiation-speciﬁc changes in pre-mRNA splicing.
Furthermore, we propose that Fox-1 related proteins represent
the core of the conserved regulatory machinery that mediates
these splicing switches. Direct experimental evidence for
Fox-1 splicing regulation via (U)GCAUG motif(s) has been
reported (35). Moreover, the RRM domains of human A2BP1/
Fox-1 (46) and zebraﬁsh Fox-1 (35) are highly conserved
( 91% identity), and comparative genomic analysis indicates
that this domain inthe mouse, dog, ratand chicken orthologs is
identical to human Fox-1 (our unpublished observations).
Thus, the UGCAUG-Fox-1 system appears to have been
highly conserved through evolution. The unique sequence spe-
ciﬁcity of this machinery may be an advantageous property for
a splicing regulatory network designed to regulate a restricted
population of exons in tissue-speciﬁc splicing patterns.
However, a single isoform of Fox-1 alone clearly cannot
account for the diversity of splicing patterns characteristic
of complex genes in metazoan organisms. Indeed, the proteo-
me’s repertoire of Fox proteins may be fairly complex,
involving multiple genes and multiple protein isoforms en-
coded by each gene. Future studies will be required to assess
the relative RNA binding speciﬁcities and co-factor binding
capabilities for each Fox isoform, in order to elucidate the
rules that govern this regulatory system. Such studies may
explain why the zebraﬁsh Fox-1 preferentially binds the
GCAUG pentamer in SELEX binding assays (35), yet
the UGCAUG hexamer exhibits preferential conservation in
the genome.Moreover, itseems likelythatavarietyofsplicing
co-factors must cooperate with Fox proteins to activate spli-
cing switches for highly selective groups of exons at the
appropriate time and place during development. Such
co-factors may include members of the SR and hnRNP fam-
ilies, factors related to NOVA-1 (47) or CUG-binding proteins
of the CELF family (22), or proteins yet to be characterized.
Future experiments will be aimed at identifying additional
motifs and co-factors that cooperate with UGCAUG-Fox to
SCN8a
Br H K Li Lu Sk
EPB41L3s
Br H K Li Lu Sk
PTBP2
Br H K Li Lu Sk
MYH10
Br H K Li Lu Sk
ACVR2
Br H K Li Lu Sk
NF1
Br H K Li Lu Sk
EPB41L1s
Br H K Li Lu Sk
EPB41L3b
Br H K Li Lu Sk
Figure 4. Alternative splicingof brain-enrichedalternativeexons is conserved
in mouse. Alternative splicing of brain-enriched exons was examined by RT–
PCR analysis of RNA isolated from six different mouse tissues. The figure
shows polyacrylamide gel analyses indicating the amplification of brain-
enriched isoforms (filled arrowheads) and non-tissue-specific isoforms (open
arrowheads). The identity of the alternative exons is identified above each gel.
TissuesusedforPCRanalysis:Br,brain;H,heart;K,kidney;Li,liver;Lu,lung
and Sk, skeletal muscle.
722 Nucleic Acids Research, 2005, Vol. 33, No. 2determine precise timing of splicing switches in various cell
types.
ACKNOWLEDGEMENTS
The authors thank Thomas Cooper for very helpful comments
on the manuscript. This work was supported by National
Institutes of Health (NIH) grant HL45182 and by the
Director, Office of Biological and Environmental Research,
US Department of Energy under contract DE-AC03-
76SF00098. Funding to pay the Open Access publication
charges for this article was provided by NIH grant HL45182.
REFERENCES
1. Zhu,J., Mayeda,A. and Krainer,A.R. (2001) Exon identity established
through differential antagonism between exonic splicing silencer-bound
hnRNP A1 and enhancer-bound SR proteins. Mol. Cell, 8, 1351–1361.
2. Charlet,B.N., Logan,P., Singh,G. and Cooper,T.A. (2002) Dynamic
antagonism between ETR-3 and PTB regulates cell type-specific
alternative splicing. Mol. Cell., 9, 649–658.
3. Rooke,N.,Markovtsov,V.,Cagavi,E.andBlack,D.L.(2003)RolesforSR
proteins and hnRNP A1 in the regulation of c-src exon N1.
Mol. Cell. Biol., 23, 1874–1884.
4. Tacke,R. and Manley,J.L. (1995) The human splicing factors ASF/SF2
and SC35 possess distinct, functionally significant RNA binding
specificities. EMBO J., 14, 3540–3551.
5. Coulter,L.R., Landree,M.A. and Cooper,T.A. (1997) Identification of a
new class of exonic splicing enhancers by in vivo selection [Erratum
(1997) Mol. Cell. Biol., 17, 3468.]. Mol. Cell. Biol., 17, 2143–2150.
6. Liu,H.X.,Zhang,M.andKrainer,A.R.(1998)Identificationoffunctional
exonic splicing enhancer motifs recognized by individual SR proteins.
Genes Dev., 12, 1998–2012.
7. Schaal,T.D. and Maniatis,T. (1999) Selection and characterization of
pre-mRNA splicing enhancers: identification of novel SR
protein-specific enhancer sequences. Mol. Cell Biol., 19, 1705–1719.
8. Cavaloc,Y., Bourgeois,C.F., Kister,L. and Stevenin,J. (1999)
The splicing factors 9G8 and SRp20 transactivate splicing through
different and specific enhancers. RNA, 5, 468–483.
9. Liu,H.X., Chew,S.L., Cartegni,L., Zhang,M.Q. and Krainer,A.R. (2000)
Exonic splicing enhancer motif recognized by human SC35 under
splicing conditions. Mol. Cell. Biol., 20, 1063–1071.
10. Kim,S., Shi,H., Lee,D.K. and Lis,J.T. (2003) Specific SR
protein-dependent splicing substrates identified through genomic
SELEX. Nucleic Acids Res., 31, 1955–1961.
11. Wang,Z., Rolish,M.E., Yeo,G., Tung,V., Mawson,M. and Burge,C.B.
(2004)Systematicidentificationandanalysisofexonicsplicingsilencers.
Cell, 119, 831–845.
12. Fairbrother,W.G., Yeh,R.F., Sharp,P.A. and Burge,C.B. (2002)
Predictive identification of exonic splicing enhancers in human genes.
Science, 297, 1007–1013.
13. Yeo,G., Hoon,S., Venkatesh,B. and Burge,C.B. (2004) Variation in
sequence and organization of splicing regulatory elements in vertebrate
genes. Proc. Natl Acad. Sci. USA, 101, 15700–15705.
14. Zhang,X.H. and Chasin,L.A. (2004) Computational definition of
sequence motifs governing constitutive exon splicing. Genes Dev.,
18, 1241–1250.
15. Brudno,M., Gelfand,M.S., Spengler,S., Zorn,M., Dubchak,I. and
Conboy,J.G. (2001) Computational analysis of candidate intron
regulatory elements for tissue-specific alternative pre-mRNA splicing.
Nucleic Acids Res., 29, 2338–2348.
16. Cartegni,L., Wang,J., Zhu,Z., Zhang,M.Q. and Krainer,A.R. (2003)
ESEfinder:awebresourcetoidentifyexonicsplicingenhancers.Nucleic
Acids Res., 31, 3568–3571.
17. Fairbrother,W.G., Yeo,G.W., Yeh,R., Goldstein,P., Mawson,M.,
Sharp,P.A. and Burge,C.B. (2004) RESCUE-ESE identifies candidate
exonic splicing enhancers in vertebrate exons. Nucleic Acids Res.,
32, W187–W190.
18. Modafferi,E.F. and Black,D.L. (1997) A complex intronic splicing
enhancerfromthec-srcpre-mRNAactivatesinclusionofaheterologous
exon. Mol. Cell. Biol., 17, 6537–6545.
19. Blanchette,M. and Chabot,B. (1999) Modulation of exon skipping by
high-affinityhnRNPA1-bindingsitesandbyintronelementsthatrepress
splice site utilization. EMBO J., 18, 1939–1952.
20. Gromak,N., Matlin,A.J., Cooper,T.A. and Smith,C.W. (2003)
Antagonistic regulation of alpha-actinin alternative splicing by CELF
proteins and polypyrimidine tract binding protein. RNA, 9,
443–456.
21. Forch,P., Puig,O., Martinez,C., Seraphin,B. and Valcarcel,J. (2002) The
splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP
recruitment to 50 splice sites. EMBO J., 21, 6882–6892.
22. Ladd,A.N.,Charlet,N.andCooper,T.A.(2001)TheCELFfamilyofRNA
binding proteins is implicated in cell-specific and developmentally
regulated alternative splicing. Mol. Cell. Biol., 21,
1285–1296.
23. Ule,J.,Jensen,K.B.,Ruggiu,M.,Mele,A.,Ule,A.andDarnell,R.B.(2003)
CLIP identifies Nova-regulated RNA networks in the brain. Science,
302, 1212–1215.
24. Huh,G.S. and Hynes,R.O. (1994) Regulation of alternative pre-mRNA
splicing by a novel repeated hexanucleotide element. Genes Dev.,
8, 1561–1574.
25. Hedjran,F., Yeakley,J.M., Huh,G.S., Hynes,R.O. and Rosenfeld,M.G.
(1997) Control of alternative pre-mRNA splicing by distributed
pentameric repeats. Proc. Natl Acad. Sci. USA, 94, 12343–12347.
26. Kawamoto,S. (1996) Neuron-specific alternative splicing of nonmuscle
myosin II heavy chain-B pre-mRNA requires a cis-acting intron
sequence. J. Biol. Chem., 271, 17613–17616.
27. Lim,L.P. and Sharp,P.A. (1998) Alternative splicing of the fibronectin
EIIIB exon depends on specific TGCATG repeats. Mol. Cell. Biol.,
18, 3900–3906.
28. Parra,M., Gee,S., Chan,N., Ryaboy,D., Dubchak,I., Mohandas,N.,
Gascard,P.D.andConboy,J.G.(2004)Differentialdomainevolutionand
complex RNA processing in a family of paralogous EPB41 (protein 4.1)
genesfacilitateexpressionofdiversetissue-specificisoforms.Genomics,
84, 637–646.
29. Gallagher,P.G.,Tse,W.T.,Scarpa,A.L.,Lux,S.E.andForget,B.G.(1997)
Structure and organization of the human ankyrin-1 gene. Basis for
complexityofpre-mRNAprocessing.J.Biol.Chem.,272,19220–19228.
30. Laura,R.P., Ross,S., Koeppen,H. and Lasky,L.A. (2002) MAGI-1: a
widely expressed, alternatively spliced tight junction protein.
Exp. Cell Res., 275, 155–170.
31. Burgess,H.A. and Reiner,O. (2002) Alternative splice variants of
doublecortin-like kinase are differentially expressed and have different
kinase activities. J. Biol. Chem., 277, 17696–17705.
32. Melot,T.,Dauphinot,L., Sevenet,N.,Radvanyi,F. and Delattre,O.(2001)
Characterizationofanewbrain-specificisoformoftheEWSoncoprotein.
Eur. J. Biochem., 268, 3483–3489.
33. Itoh,K. and Adelstein,R.S. (1995) Neuronal cell expression of inserted
isoforms of vertebrate nonmuscle myosin heavy chain II-B.
J. Biol. Chem., 270, 14533–14540.
34. Rahman,L., Bliskovski,V., Reinhold,W. and Zajac-Kaye,M. (2002)
Alternative splicing of brain-specific PTB defines a tissue-specific
isoform pattern that predicts distinct functional roles. Genomics,
80, 245–249.
35. Jin,Y., Suzuki,H., Maegawa,S., Endo,H., Sugano,S., Hashimoto,K.,
Yasuda,K.andInoue,K.(2003)AvertebrateRNA-bindingproteinFox-1
regulates tissue-specific splicing via the pentanucleotide GCAUG.
EMBO J., 22, 905–912.
36. Sorek,R. and Ast,G. (2003) Intronic sequences flanking alternatively
spliced exons are conserved between human and mouse. Genome Res.,
13, 1631–1637.
37. Sorek,R., Lev-Maor,G., Reznik,M., Dagan,T., Belinky,F., Graur,D. and
Ast,G.(2004) Minimalconditionsfor exonization of intronicsequences:
50 splice site formation in alu exons. Mol. Cell, 14, 221–231.
38. Nussinov,R. (1989) Conserved signals around the 50 splice sites in
eukaryotic nuclear precursor mRNAs: G-runs are frequent in the introns
andCintheexonsnearboth50 and30 splicesites.J.Biomol.Struct.Dyn.,
6, 985–1000.
39. Sirand-Pugnet,P., Durosay,P., Brody,E. and Marie,J. (1995) An intronic
(A/U)GGG repeat enhances the splicing of an alternative intron of the
chicken beta-tropomyosin pre-mRNA. Nucleic Acids Res., 23,
3501–3507.
40. McCullough,A.J. and Berget,S.M. (1997) G triplets located throughout
a class of small vertebrate introns enforce intron borders and regulate
splice site selection. Mol. Cell. Biol., 17, 4562–4571.
Nucleic Acids Research, 2005, Vol. 33, No. 2 72341. McCullough,A.J. and Berget,S.M. (2000) An intronic splicing enhancer
bindsU1snRNPstoenhancesplicingandselect50 splicesites.Mol.Cell.
Biol., 20, 9225–9235.
42. Nurtdinov,R.N., Artamonova,I.I., Mironov,A.A. and Gelfand,M.S.
(2003)Lowconservationofalternativesplicingpatternsinthehumanand
mouse genomes. Hum. Mol. Genet., 12, 1313–1320.
43. Sorek,R., Shamir,R. and Ast,G. (2004) How prevalent is functional
alternative splicing in the human genome?. Trends Genet., 20, 68–71.
44. Guo,N. and Kawamoto,S. (2000) An intronic downstream enhancer
promotes30 splicesiteusageofaneuralcell-specificexon.J.Biol.Chem.,
275, 33641–33649.
45. Zhang,X.H., Heller,K.A., Hefter,I., Leslie,C.S. and Chasin,L.A. (2003)
Sequence information for the splicing of human pre-mRNA identified
by support vector machine classification. Genome Res., 13,
2637–2650.
46. Shibata,H., Huynh,D.P. and Pulst,S.M. (2000) A novel protein with
RNA-binding motifs interacts with ataxin-2. Hum. Mol. Genet.,
9, 1303–1313.
47. Jensen,K.B., Dredge,B.K., Stefani,G., Zhong,R., Buckanovich,R.J.,
Okano,H.J., Yang,Y.Y. and Darnell,R.B. (2000) Nova-1 regulates
neuron-specificalternativesplicingandisessentialforneuronalviability.
Neuron, 25, 359–371.
724 Nucleic Acids Research, 2005, Vol. 33, No. 2